 | A comprehensive genomics facility for the UQ Diamantina Institute for Cancer, Immunology and Metabolic Medicine, 2008 - 2015
Funded by: Australian Cancer Research Foundation, PA Foundation |
| Studying the function of antigen experienced CD4+GITR+T cells, 2008 - 2008
Funded by: PA Foundation |
| RNA interference to boost immune responses against cancer, 2008 - 2009
Funded by: Cancer Council Queensland |
| Genetic and Genomic Analysis Research Facility, 2007 - 2007
Funded by: RL Cooper Medical Research Foundation Limited |
| Non-viral vectors for targeted delivery of RNAi nucleotides to cervical cancers, 2007 - 2009
Funded by: National Health and Medical Research Council |
| MPM non-invasive imaging of biological interactions following drug delivery with micro-nanoprojection patches, 2007 - 2009
Funded by: National Health and Medical Research Council |
| Improving Immunotherapy by Inhibiting IL 10 Mediated Immune Deviation, 2006 - 2007
Funded by: National Health and Medical Research Council |
| Jet break-up of emulsions for the production of designer micro particulate drug delivery systems - Administering Institution JCU, 2005 - 2007
Funded by: James Cook University |
| Immunological therapies for cancer and autoimmunity, 2005 - 2009
Funded by: National Health and Medical Research Council |
| Optimising Immunotherapy in Tumour Antigen Experienced Host, 2005 - 2006
Funded by: Queensland Cancer Fund |
| The role of NKT and CD8 cells in tumour immunotherapy using epithelial tumour models, 2005 - 2006
Funded by: Queensland Cancer Fund |
| Study Of HPV 6L1 Virus Like Particles As Therapeutic Vaccine For Genital Warts And Recurrent Respiratory Papillomatosis, 2003 - 2010
Funded by: Wellcome Australia Limited |
| PAHF block funding, 2003 - 2004
Funded by: Princess Alexandra Hospital Auxiliary |
| Evaluating Therapeutic Interventions to Overcome Tolerance to Tumour Antigen, 2003 - 2004
Funded by: Queensland Cancer Fund |
| A phase IB trial of virus like particle immunotherapy for HPV associated infection, 2005 - 2007
Funded by: Cancer Research Institute (USA) |
| A skin graft model of immunotherapy for cervical cancer., 2002 - 2002
Funded by: Princess Alexandra Hospital Auxiliary |
| Effective immunotherapy for HPV associated cervical cancer precusor lesions, 2002 - 2004
Funded by: National Health and Medical Research Council |
| How does tRNA correlate with codon usage to regulate the expression of papillomavirus late genes?, 2002 - 2003
Funded by: Queensland Cancer Fund |
| Codon usage/tRNA matching: a novel method of gene regulation in plants, 2001 - 2004
Funded by: Grains Research & Development Corporation |
| A Phase 1B Trial of Specific Immunotherapy for Recurrent Respiratory Papillomatosis, 2001 - 2002
Funded by: National Health and Medical Research Council |
| CTL Avidity as a Determinant of the Mature, Antigen-specific Immune Repertoire, 2001 - 2003
Funded by: National Health and Medical Research Council |
| Can Response To The Antiviral Drug Lmiquimod Be Predicted By Pretreatment Genetic Testing? A Phase 4 Clinical Trial, 2001 - 2001
Funded by: Princess Alexandra Hospital Auxiliary |
| Endogenous Antigen Presentation By Epithelial Tumours, 2001 - 2001
Funded by: Princess Alexandra Hospital Auxiliary |
| A model for epithelial tumour immunotherapy, 2000 - 2000
Funded by: Princess Alexandra Hospital Auxiliary |
| Identification of papilolomavirus epitopes recognised in man, and development of human anti-HPV monoclonal antibodies, 2000 - 2000
Funded by: Cancer Bequest Fund |
| Page: | 1 2 3  |
| |
| Select all records |
| |
